SCHEMBL1243558

SCHEMBL1243558

NCc1[c]occ1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3651286 0.78
SCHEMBL467306 0.74
SCHEMBL1768412 0.74
SCHEMBL4729422 0.70
SCHEMBL3947126 0.69
SCHEMBL2454500 0.67
SCHEMBL2351201 0.67 CALM1 (0.46)
SCHEMBL18396913 0.66
SCHEMBL18396886 0.66
SCHEMBL1727698 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4436903-A Process for the production of 7 β-substituted-3-unsubstituted-3-cephem-4-carboxylic acid compounds CIBA-GEIGY CORPORATION (US) 1984-03-13 US claimed
EP-0087274-A2 Pyrimidone derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-08-31 EP claimed
EP-0016725-B1 PROCESS FOR THE PREPARATION OF 3-HYDROXYCEPHAM COMPOUNDS CIBA-GEIGY AG (CH) 1983-03-23 EP claimed
US-4301279-A Process for the production of 3-hydroxy compounds CIBA-GEIGY CORPORATION (US) 1981-11-17 US claimed
US-4248868-A FOR TREATING SYSTEMIC INFECTIONS BY GRAMPOSITIVE AND GRAM NEGATIVE BACTERIA CIBA-GEIGY CORPORATION (US) 1981-02-03 US claimed
EP-0016725-A1 Process for the preparation of 3-hydroxycepham compounds CIBA-GEIGY AG (CH) 1980-10-01 EP claimed
US-4070477-A PENICILLINS CIBA-GEIGY CORPORATION (US) 1978-01-24 US claimed
EP-1797096-B1 PYRAZOLOPYRIMIDINES AS INHIBITORS OF PROTEIN KINASE B (AKT) BAYER SCHERING PHARMA AG (DE) 2011-07-27 EP disclosed
US-7879853-B2 tyrosisne kinase inhibitors such as N-[4-(6-Dibenzofuran-4-yl-pyrimidin-4-ylamino)-phenyl]-4-morpholin-4-yl-benzamide, used as anticasrcinogenic or antoproliferative agents, especially in the treatment of breast cancer BAYER SCHERING PHARMA AG (DE) 2011-02-01 US disclosed
US-7745446-B2 Pyrazolo[1,5-c]pyrimidines BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-29 US disclosed
EP-1763526-B1 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AG (DE) 2009-06-24 EP disclosed
US-20070254046-A1 Novel Pyrazolopyrimidines ALTANA PHARMA AG (DE) 2007-11-01 US disclosed
US-20070208034-A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors ATLANTA PHARMA AG (DE) 2007-09-06 US disclosed
EP-0016725-B1 PROCESS FOR THE PREPARATION OF 3-HYDROXYCEPHAM COMPOUNDS CIBA-GEIGY AG (CH) 1983-03-23 EP disclosed
US-4364865-A ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1982-12-21 US disclosed
EP-0055217-A2 Process for the preparation of derivatives of 7-beta-substituted 3-cephem-4-carboxylic acids not substituted in position 3 CIBA-GEIGY AG (CH) 1982-06-30 EP disclosed
US-4301279-A Process for the production of 3-hydroxy compounds CIBA-GEIGY CORPORATION (US) 1981-11-17 US disclosed
US-4248868-A FOR TREATING SYSTEMIC INFECTIONS BY GRAMPOSITIVE AND GRAM NEGATIVE BACTERIA CIBA-GEIGY CORPORATION (US) 1981-02-03 US disclosed
EP-0016725-A1 Process for the preparation of 3-hydroxycepham compounds CIBA-GEIGY AG (CH) 1980-10-01 EP disclosed
US-4070477-A PENICILLINS CIBA-GEIGY CORPORATION (US) 1978-01-24 US disclosed